Fellowship · Dallas, TX
Sponsored by University of Texas Southwestern Medical Center
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
The New England journal of medicine · 2021 · 427 citations · David Sas
The genetics of kidney stone disease and nephrocalcinosis.
Nature reviews. Nephrology · 2022 · 185 citations · David Sas
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
The lancet. Diabetes & endocrinology · 2022 · 155 citations · Robert Haws
Kidney Health Monitoring in Neonatal Intensive Care Unit Graduates: A Modified Delphi Consensus Statement.
JAMA network open · 2024 · 38 citations · Catherine Joseph
Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024 · 34 citations · Catherine Joseph
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Kidney international · 2023 · 77 citations ·
Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study.
Pediatric nephrology (Berlin, Germany) · 2025 · 21 citations · Catherine Joseph
Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury.
Advanced materials (Deerfield Beach, Fla.) · 2023 · 72 citations · Diana Zepeda-Orozco